It is a pharma private limited company based in New Delhi, Delhi, India, established in 2019.
2019 | New Delhi, Delhi, India | ActiveBaranwal Drug Private Limited, a active private limited company, was established on 05 August 2019 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24100DL2019PTC353430. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Priti Barnwal (Director), Surendra Prasad Barnwal (Director). Past directors included Priti Barnwal, Chandan Barnwal, Santosh Kumar Barnwal. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-25, Naresh Park, Extn.Nangloi,, New Delhi, Delhi, 110041.
U24100DL2019PTC353430
353430
05 August 2019
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Baranwal Drug Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priti Barnwal | Director | 22 Feb 2024 | Current |
| Surendra Prasad Barnwal | Director | 05 Aug 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 27 Sep 2024 | Past |
| Pramod Abcsdd | Director | 24 Jan 2022 | Past |
| Pramod Abcsdd | Director | 22 Feb 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Baranwal Drug Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Baranwal Drug's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Baranwal Drug, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Baranwal Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baranwal Drug's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Baranwal Drug Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Baranwal Drug Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Priti Barnwal was appointed as a Director was appointed as a Director on 22 Feb 2024 & has been associated with this company since 1 year 9 months . was completed.
The activity Surendra Prasad Barnwal was appointed as a Director was appointed as a Director on 05 Aug 2019 & has been associated with this company since 6 years 4 months . was completed.
Progress on Baranwal Drug Private Limited was registered on 05 Aug 2019 with Roc Delhi & aged 6 years 4 months as per MCA records. was documented.
The CIN of Baranwal Drug Private Limited is U24100DL2019PTC353430.
Baranwal Drug Private Limited is headquartered at A-25, Naresh Park, Extn.Nangloi,, New Delhi, Delhi, 110041.
Baranwal Drug Private Limited was incorporated on 05 August 2019.
The current directors of Baranwal Drug Private Limited are
The primary industry of Baranwal Drug Private Limited is Pharma.
Baranwal Drug Private Limited is unlisted.
The authorized capital of Baranwal Drug Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Baranwal Drug Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX